Share your opinion and earn yourself a free Motley Fool premium report!

We are looking for Fools to join a 75 minute online independent market research forum on 15th / 16th December.

To find out more and express your interest please click here

3 top FTSE 100 shares I’d buy in July

These FTSE 100 shares should perform well in the future despite today’s uncertain outlook, says Roland Head.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Should you be buying shares when the economic outlook is so uncertain? Absolutely! I’ve found a number of FTSE 100 shares that I think will deliver strong returns to long-term investors from current levels.

Healthcare heavyweight

If you’re building a diversified, long-term portfolio, I think you need to have some exposure to the healthcare sector. It’s an essential global business for which I believe demand will only grow.

My top FTSE 100 pick in this sector is pharmaceutical giant GlaxoSmithKline (LSE: GSK). Alongside its prescription medicine and vaccine businesses, the group also has a large consumer healthcare business — home to brands such as Sensodyne and Nicorette.

Glaxo plans to seperate its consumer business into a new company over the next couple of years. This will dividen the group into two smaller and more focused businesses. I think this will improve their growth potential — good news for shareholders.

The GSK share price has now fallen by nearly 15% from the highs seen earlier this year. The shares now trade on about 13.5 times forecast earnings, with a 5% dividend yield. I think this FTSE 100 share is priced to buy.

A FTSE 100 share for tech investors

Big tech stocks are rare in the UK. One exception is cyber security software group Avast (LSE: AVST). This Prague-based firm only floated on the London market in 2018, but its continued growth has already lifted it into the FTSE 100. I think there could be more to come.

Avast’s core anti-virus product has a free version, which the firm uses to recruit users to whom it can sell additional services. The group also has a corporate business. This might sound like a small operation but it’s not — Avast has over 435m active users and generated revenue of $873m in 2019.

Operating profit margins are high, at around 40%. Cash generation is good too, which means the group’s after-tax profits are reliably converted into spare cash. The only criticism I’d make is that the firm’s growth rate is relatively low — adjusted profits rose by just 8% last year.

Despite this, I think Avast’s strong financial performance and large customer base should support continued growth. The shares currently trade on about 20 times forecast earnings, with a dividend yield of around 2.1%. I think that’s a fair price to pay for this high quality FTSE 100 share.

A fashion stock you can trust

When you invest in a company there’s always an element of risk. As outsiders we never know everything about a business. One company that tries hard to provide a level playing field is retailer Next (LSE: NXT), which is known for the quality of its financial reporting.

The bad news is that Next’s management expect sales to fall by between 30% and 40% this year. As a result, pre-tax profits are expected to fall from £728m last year to a maximum of £150m.

However, there’s good news too. Careful management means that the group’s financial position remains very strong. Net debt is actually expected to fall this year.

Another attraction is that broker forecasts suggest profits will bounce back quickly next year. If they’re correct, then this FTSE 100 share now trades on just 13 times forecast earnings.

Next is a highly profitable business with an excellent track record of shareholder returns. I’d rate the shares as a buy at this level.

Roland Head owns shares of GlaxoSmithKline. The Motley Fool UK owns shares of and has recommended GlaxoSmithKline. The Motley Fool UK owns shares of Next. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Thoughtful man using his phone while riding on a train and looking through the window
Investing Articles

Here’s how much passive income someone could earn maxing out their ISA allowance for 5 years

Christopher Ruane considers how someone might spend a few years building up their Stocks and Shares ISA to try and…

Read more »

Man putting his card into an ATM machine while his son sits in a stroller beside him.
Investing Articles

Was I wrong about Barclays shares, up 196%?

Our writer has watched Barclays shares nearly triple in five years, but stayed on the sidelines. Is he now ready…

Read more »

Wall Street sign in New York City
Investing Articles

Up 17% in 2025, can the S&P 500 power on into 2026?

Why has the S&P 500 done so well this year against a backdrop of multiple challenges? Our writer explains --…

Read more »

National Grid engineers at a substation
Investing Articles

National Grid shares are up 19% in 2025. Why?

National Grid shares have risen by almost a fifth this year. So much for it being a sleepy utility! Should…

Read more »

Road 2025 to 2032 new year direction concept
Investing Articles

Here are the potential dividend earnings from buying 1,000 Aviva shares for the next decade

Aviva has a juicy dividend -- but what might come next? Our writer digs into what the coming decade could…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

Just released: our top 3 small-cap stocks to consider buying in December [PREMIUM PICKS]

Small-cap shares tend to be more volatile than larger companies, so we suggest investors should look to build up a…

Read more »

This way, That way, The other way - pointing in different directions
Investing Articles

Is the unloved Aston Martin share price about to do a Rolls-Royce?

The Aston Martin share price has inflicted a world of pain on Harvey Jones, but he isn't giving up hope…

Read more »

Surprised Black girl holding teddy bear toy on Christmas
Investing Articles

How much do you need in a Stocks and Shares ISA to raise 1.7 children?

After discovering the cost of raising a child, James Beard explains why he thinks a Stocks and Shares ISA is…

Read more »